Home LiteratureArticle Details
PMID: 11024148 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Functional importance of the coiled-coil of the Ebola virus glycoprotein.

Journal of virology ·Vol. 74 ·No. 21 ·2000-11-00 ·Pages 10194-201

Watanabe S, Takada A, Watanabe T, Ito H, Kida H, Kawaoka Y

Abstract

Ebola virus contains a single glycoprotein (GP) that is responsible for receptor binding and membrane fusion and is proteolytically cleaved into disulfide-linked GP1 and GP2 subunits. The GP2 subunit possesses a coiled-coil motif, which plays an important role in the oligomerization and fusion activity of other viral GPs. To determine the functional significance of the coiled-coil motif of GP2, we examined the effects of peptides corresponding to the coiled-coil motif of GP2 on the infectivity of a mutant vesicular stomatitis virus (lacking the receptor-binding/fusion protein) pseudotyped with the Ebola virus GP. A peptide corresponding to the C-terminal helix reduced the infectivity of the pseudotyped virus. We next introduced alanine substitutions into hydrophobic residues in the coiled-coil motif to identify residues important for GP function. None of the substitutions affected GP oligomerization, but some mutations, two in the N-terminal helix and all in the C-terminal helix, reduced the ability of GP to confer infectivity to the mutant vesicular stomatitis virus without affecting the transport of GP to the cell surface, its incorporation into virions, and the production of virus particles. These results indicate that the coiled-coil motif of GP2 plays an important role in facilitating the entry of Ebola virus into host cells and that peptides corresponding to this region could act as efficient antiviral agents.

MeSH Terms
Amino Acid Motifs Amino Acid Sequence Amino Acid Substitution Animals Chlorocebus aethiops Ebolavirus/genetics,metabolism,pathogenicity Membrane Fusion Molecular Sequence Data Mutation Peptides/genetics,metabolism Protein Structure, Secondary Structure-Activity Relationship Vero Cells Vesicular stomatitis Indiana virus/genetics,metabolism Viral Envelope Proteins/chemistry,genetics,metabolism Viral Fusion Proteins/chemistry,genetics,metabolism
Chemicals
Peptides Viral Envelope Proteins Viral Fusion Proteins envelope glycoprotein, Ebola virus
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Watanabe S
Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.
Takada A
Watanabe T
Ito H
Kida H
Kawaoka Y
References (54)
54 references, click to expand
  1. HIV-1 entry inhibitors in the side pocket.
    Cell. 1999 Oct 29;99(3):243-6 PMID: 10555140
  2. Mutational analysis of the putative fusion domain of Ebola virus glycoprotein.
    J Virol. 1999 Oct;73(10):8907-12 PMID: 10482652
  3. Side chain contributions to the stability of alpha-helical structure in peptides.
    Science. 1990 Nov 2;250(4981):669-73 PMID: 2237416
  4. Glycosylation and oligomerization of the spike protein of Marburg virus.
    Virology. 1991 May;182(1):353-6 PMID: 2024471
  5. Efficient selection for high-expression transfectants with a novel eukaryotic vector.
    Gene. 1991 Dec 15;108(2):193-9 PMID: 1660837
  6. Folding and function of a T4 lysozyme containing 10 consecutive alanines illustrate the redundancy of information in an amino acid sequence.
    Proc Natl Acad Sci U S A. 1992 May 1;89(9):3751-5 PMID: 1570293
  7. Mutations in the leucine zipper of the human immunodeficiency virus type 1 transmembrane glycoprotein affect fusion and infectivity.
    J Virol. 1992 Aug;66(8):4748-56 PMID: 1629954
  8. A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition.
    Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10537-41 PMID: 1438243
  9. The envelope glycoprotein of Ebola virus contains an immunosuppressive-like domain similar to oncogenic retroviruses.
    FEBS Lett. 1992 Jul 6;305(3):181-4 PMID: 1299611
  10. Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein.
    J Virol. 1993 May;67(5):2747-55 PMID: 8474172
  11. Mutational analysis of the leucine zipper-like motif of the human immunodeficiency virus type 1 envelope transmembrane glycoprotein.
    J Virol. 1993 Jun;67(6):3615-9 PMID: 8497069
  12. A spring-loaded mechanism for the conformational change of influenza hemagglutinin.
    Cell. 1993 May 21;73(4):823-32 PMID: 8500173
  13. HIV-1 inhibition by a peptide.
    Nature. 1993 Sep 9;365(6442):113 PMID: 8371754
  14. Paramyxovirus fusion: a hypothesis for changes.
    Virology. 1993 Nov;197(1):1-11 PMID: 8212546
  15. Molecular biology and evolution of filoviruses.
    Arch Virol Suppl. 1993;7:81-100 PMID: 8219816
  16. Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus.
    Virus Res. 1993 Sep;29(3):215-40 PMID: 8237108
  17. Functional role of the zipper motif region of human immunodeficiency virus type 1 transmembrane protein gp41.
    J Virol. 1994 Mar;68(3):2002-10 PMID: 7509005
  18. Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein.
    Virology. 1994 Mar;199(2):469-73 PMID: 8122375
  19. Structure of influenza haemagglutinin at the pH of membrane fusion.
    Nature. 1994 Sep 1;371(6492):37-43 PMID: 8072525
  20. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.
    Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9770-4 PMID: 7937889
  21. Oligomerization of the hydrophobic heptad repeat of gp41.
    J Virol. 1995 May;69(5):2745-50 PMID: 7707497
  22. Mutational analysis of the leucine zipper motif in the Newcastle disease virus fusion protein.
    J Virol. 1995 Oct;69(10):5995-6004 PMID: 7666504
  23. A synthetic peptide corresponding to a conserved heptad repeat domain is a potent inhibitor of Sendai virus-cell fusion: an emerging similarity with functional domains of other viruses.
    EMBO J. 1995 Nov 15;14(22):5524-31 PMID: 8521809
  24. The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing.
    Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3602-7 PMID: 8622982
  25. Retrovirus envelope domain at 1.7 angstrom resolution.
    Nat Struct Biol. 1996 May;3(5):465-9 PMID: 8612078
  26. Similar structural models of the transmembrane proteins of Ebola and avian sarcoma viruses.
    Cell. 1996 May 17;85(4):477-8 PMID: 8653783
  27. Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.
    Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91 PMID: 8700906
  28. Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses.
    Arch Virol Suppl. 1996;11:135-40 PMID: 8800795
  29. Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection.
    Virology. 1996 Sep 1;223(1):103-12 PMID: 8806544
  30. Human immunodeficiency virus type 1 envelope glycoprotein oligomerization requires the gp41 amphipathic alpha-helical/leucine zipper-like sequence.
    J Virol. 1997 Mar;71(3):2041-9 PMID: 9032336
  31. Core structure of gp41 from the HIV envelope glycoprotein.
    Cell. 1997 Apr 18;89(2):263-73 PMID: 9108481
  32. Atomic structure of the ectodomain from HIV-1 gp41.
    Nature. 1997 May 22;387(6631):426-30 PMID: 9163431
  33. Atomic structure of a thermostable subdomain of HIV-1 gp41.
    Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12303-8 PMID: 9356444
  34. A system for functional analysis of Ebola virus glycoprotein.
    Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14764-9 PMID: 9405687
  35. Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins.
    Science. 1998 Feb 13;279(5353):1034-7 PMID: 9461435
  36. Phosphatidylinositol-dependent membrane fusion induced by a putative fusogenic sequence of Ebola virus.
    J Virol. 1998 Mar;72(3):1775-81 PMID: 9499027
  37. The M2 ectodomain is important for its incorporation into influenza A virions.
    J Virol. 1998 Mar;72(3):2449-55 PMID: 9499106
  38. Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines.
    J Virol. 1998 Apr;72(4):3155-60 PMID: 9525641
  39. Processing of the Ebola virus glycoprotein by the proprotein convertase furin.
    Proc Natl Acad Sci U S A. 1998 May 12;95(10):5762-7 PMID: 9576958
  40. HIV entry and its inhibition.
    Cell. 1998 May 29;93(5):681-4 PMID: 9630213
  41. Biochemical analysis of the secreted and virion glycoproteins of Ebola virus.
    J Virol. 1998 Aug;72(8):6442-7 PMID: 9658086
  42. Crystal structure of the simian immunodeficiency virus (SIV) gp41 core: conserved helical interactions underlie the broad inhibitory activity of gp41 peptides.
    Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9134-9 PMID: 9689046
  43. A core trimer of the paramyxovirus fusion protein: parallels to influenza virus hemagglutinin and HIV-1 gp41.
    Virology. 1998 Aug 15;248(1):20-34 PMID: 9705252
  44. Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41.
    EMBO J. 1998 Aug 17;17(16):4572-84 PMID: 9707417
  45. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry.
    Nat Med. 1998 Nov;4(11):1302-7 PMID: 9809555
  46. Mutational analysis of residues in the coiled-coil domain of human immunodeficiency virus type 1 transmembrane protein gp41.
    J Virol. 1998 Dec;72(12):9676-82 PMID: 9811701
  47. Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain.
    Mol Cell. 1998 Nov;2(5):605-16 PMID: 9844633
  48. Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target.
    Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15613-7 PMID: 9861018
  49. Paramyxovirus fusion protein: characterization of the core trimer, a rod-shaped complex with helices in anti-parallel orientation.
    Virology. 1999 Feb 1;254(1):147-59 PMID: 9927582
  50. Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-A resolution.
    Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):2662-7 PMID: 10077567
  51. Structural basis for paramyxovirus-mediated membrane fusion.
    Mol Cell. 1999 Mar;3(3):309-19 PMID: 10198633
  52. Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteins.
    Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4319-24 PMID: 10200260
  53. Amino acid substitutions within the leucine zipper domain of the murine coronavirus spike protein cause defects in oligomerization and the ability to induce cell-to-cell fusion.
    J Virol. 1999 Oct;73(10):8152-9 PMID: 10482565
  54. DNA sequencing with chain-terminating inhibitors.
    Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463-7 PMID: 271968
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2000-11-00
Pages
10194-201
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC102058
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com